Silo Pharma (SILO) Total Non-Current Liabilities (2020 - 2025)
Silo Pharma (SILO) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $649476.0 as the latest value for Q4 2025.
- Quarterly Total Non-Current Liabilities fell 9.99% to $649476.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $649476.0 through Dec 2025, down 9.99% year-over-year, with the annual reading at $649476.0 for FY2025, 9.99% down from the prior year.
- Total Non-Current Liabilities hit $649476.0 in Q4 2025 for Silo Pharma, down from $667502.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $973935.0 in Q2 2021 to a low of $649476.0 in Q4 2025.
- Historically, Total Non-Current Liabilities has averaged $818439.0 across 5 years, with a median of $820718.5 in 2023.
- Biggest five-year swings in Total Non-Current Liabilities: soared 21988.65% in 2021 and later dropped 9.99% in 2025.
- Year by year, Total Non-Current Liabilities stood at $937884.0 in 2021, then dropped by 7.69% to $865782.0 in 2022, then dropped by 8.33% to $793680.0 in 2023, then decreased by 9.08% to $721578.0 in 2024, then dropped by 9.99% to $649476.0 in 2025.
- Business Quant data shows Total Non-Current Liabilities for SILO at $649476.0 in Q4 2025, $667502.0 in Q3 2025, and $685527.0 in Q2 2025.